John Joseph Johnston Maxcyte, Inc. (MXCT) insider trading activity

John Joseph Johnston is of MAXCYTE, INC.. Currently has a direct ownership of 141,950 shares of MXCT, which is worth approximately $503,922. The most recent transaction as insider was on Oct 28, 2024, when has been sold 3,000 shares (Common Stock) at a price of $3.72 per share, resulting in proceeds of $11,160. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 142K

0% 3M change

17.72% 12M change

Total Value Held $503,922

John Joseph Johnston Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 28 2024	SELL Open market or private sale	$11,160 $3.72 p/Share	3,000 Reduced 2.07%	141,950 Common Stock
Oct 28 2024	BUY Exercise of conversion of derivative security	$8,790 $2.93 p/Share	3,000 Added 2.03%	144,950 Common Stock
Sep 26 2024	SELL Open market or private sale	$11,460 $3.82 p/Share	3,000 Reduced 2.07%	141,950 Common Stock
Sep 26 2024	BUY Exercise of conversion of derivative security	$8,790 $2.93 p/Share	3,000 Added 2.03%	144,950 Common Stock
Aug 26 2024	SELL Open market or private sale	$12,840 $4.28 p/Share	3,000 Reduced 2.07%	141,950 Common Stock
Aug 26 2024	BUY Exercise of conversion of derivative security	$8,790 $2.93 p/Share	3,000 Added 2.03%	144,950 Common Stock
Jul 26 2024	SELL Open market or private sale	$14,250 $4.75 p/Share	3,000 Reduced 2.07%	141,950 Common Stock
Jul 26 2024	BUY Exercise of conversion of derivative security	$8,790 $2.93 p/Share	3,000 Added 2.03%	144,950 Common Stock
Jun 27 2024	SELL Open market or private sale	$39,900 $3.99 p/Share	10,000 Reduced 6.58%	141,950 Common Stock
Jun 27 2024	BUY Exercise of conversion of derivative security	$22,900 $2.29 p/Share	10,000 Added 6.17%	151,950 Common Stock
Jun 11 2024	BUY Grant, award, or other acquisition	-	21,367 Added 13.08%	141,950 Common Stock
Mar 26 2024	SELL Open market or private sale	$22,050 $4.41 p/Share	5,000 Reduced 3.98%	120,583 Common Stock
Mar 26 2024	BUY Exercise of conversion of derivative security	$10,700 $2.14 p/Share	5,000 Added 3.83%	125,583 Common Stock
Feb 26 2024	SELL Open market or private sale	$23,000 $4.6 p/Share	5,000 Reduced 3.98%	120,583 Common Stock
Feb 26 2024	BUY Exercise of conversion of derivative security	$10,700 $2.14 p/Share	5,000 Added 3.83%	125,583 Common Stock
Jan 26 2024	SELL Open market or private sale	$25,600 $5.12 p/Share	5,000 Reduced 3.98%	120,583 Common Stock
Jan 26 2024	BUY Exercise of conversion of derivative security	$10,700 $2.14 p/Share	5,000 Added 3.83%	125,583 Common Stock
Dec 26 2023	SELL Open market or private sale	$22,650 $4.53 p/Share	5,000 Reduced 3.98%	120,583 Common Stock
Dec 26 2023	BUY Exercise of conversion of derivative security	$10,700 $2.14 p/Share	5,000 Added 3.83%	125,583 Common Stock
Nov 27 2023	SELL Open market or private sale	$22,950 $4.59 p/Share	5,000 Reduced 3.98%	120,583 Common Stock
Nov 27 2023	BUY Exercise of conversion of derivative security	$10,700 $2.14 p/Share	5,000 Added 3.83%	125,583 Common Stock
Nov 14 2023	SELL Open market or private sale	$37,100 $3.71 p/Share	10,000 Reduced 7.66%	120,583 Common Stock
Nov 14 2023	BUY Exercise of conversion of derivative security	$18,900 $1.89 p/Share	10,000 Added 7.11%	130,583 Common Stock
Aug 30 2023	SELL Open market or private sale	$10,511 $3.7 p/Share	2,841 Reduced 2.3%	120,583 Common Stock
Aug 30 2023	BUY Exercise of conversion of derivative security	$4,659 $1.64 p/Share	2,841 Added 2.25%	123,424 Common Stock

JJJ

John Joseph Johnston

Gaithersburg, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MXCT shares.

Notify only if

Value

Insider Trading

Get notified when an Maxcyte, Inc. insider buys or sells MXCT shares.

Notify only if

Operation

Value

Type

News

Receive news related to MAXCYTE, INC.

Track Activities on MXCT

Account